AU1316201A - Polypeptide composition - Google Patents

Polypeptide composition

Info

Publication number
AU1316201A
AU1316201A AU13162/01A AU1316201A AU1316201A AU 1316201 A AU1316201 A AU 1316201A AU 13162/01 A AU13162/01 A AU 13162/01A AU 1316201 A AU1316201 A AU 1316201A AU 1316201 A AU1316201 A AU 1316201A
Authority
AU
Australia
Prior art keywords
polypeptide composition
polypeptide
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13162/01A
Other languages
English (en)
Inventor
Jay Henis
Vladimir Alexandrovich Knyazhev
Jury Viktorovich Natochin
Nikolai Alfredovich Plate
Nataliya Pavlovna Prutskova
Elena Iliinichna Shakhmatova
Ljudmila Konstantinovna Staroseltseva
Gennady Alexeevich Sytov
Mariya Viktorovna Uliyanova
Lev Ivanovich Valuev
Ljudmila Vitalievna Vanchugova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Neftekhimicheskogo Sinteza Imeni Avto Pchieva Rossiiskoi Akademii Nauk (inkhsran)
Original Assignee
INST NEFTECHIMICHESKOGO SINTEZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU99122655A external-priority patent/RU2171687C2/ru
Application filed by INST NEFTECHIMICHESKOGO SINTEZ filed Critical INST NEFTECHIMICHESKOGO SINTEZ
Publication of AU1316201A publication Critical patent/AU1316201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU13162/01A 1999-10-28 2000-10-27 Polypeptide composition Abandoned AU1316201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RO99122655 1999-10-28
RU99122655A RU2171687C2 (ru) 1999-10-28 Полипептидная композиция
PCT/RU2000/000427 WO2001030373A1 (fr) 1999-10-28 2000-10-27 Composition polypeptidique

Publications (1)

Publication Number Publication Date
AU1316201A true AU1316201A (en) 2001-05-08

Family

ID=20226315

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13162/01A Abandoned AU1316201A (en) 1999-10-28 2000-10-27 Polypeptide composition

Country Status (6)

Country Link
AU (1) AU1316201A (sh)
DE (1) DE10085144T1 (sh)
DK (1) DK200200624A (sh)
IL (1) IL149355A0 (sh)
WO (1) WO2001030373A1 (sh)
YU (1) YU31902A (sh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201701404D0 (en) 2017-01-27 2017-03-15 Micropharm Ltd Therapies for treating inflammatory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ250844A (en) * 1993-04-07 1996-03-26 Pfizer Treatment of non-insulin dependant diabetes with peptides; composition
RU2076733C1 (ru) * 1994-03-23 1997-04-10 Институт нефтехимического синтеза им.А.В.Топчеева РАН Способ получения производных инсулина
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form

Also Published As

Publication number Publication date
WO2001030373A1 (fr) 2001-05-03
IL149355A0 (en) 2002-11-10
YU31902A (sh) 2004-12-31
WO2001030373A8 (fr) 2002-02-07
DE10085144T1 (de) 2003-04-24
DK200200624A (da) 2002-06-21

Similar Documents

Publication Publication Date Title
AU4318000A (en) Agarobiose-containing composition
AU1290501A (en) Composition
AU6045900A (en) Interaction-activated proteins
AU1020300A (en) Improved cement composition
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU2001284418A1 (en) Novel polypeptide
AU8121998A (en) Composition
AU4930399A (en) Novel Polypeptide
AU5706000A (en) Useful polypeptide
AUPP332898A0 (en) Pharmaceutical composition
AU1098499A (en) Emulsifier-lipid composition
AU2691500A (en) Novel polypeptide
AU6310600A (en) Composition
AU4778600A (en) Novel polypeptide
AU1881200A (en) Novel proteins
AU6866400A (en) Bleacher composition
AU5567600A (en) Hairdye composition
AU1184800A (en) Novel polypeptide
AU2109200A (en) Polypeptide
AU6610500A (en) Antidiscoloration composition
AU5078700A (en) Novel composition
AU6712600A (en) Polypeptides
AU1228201A (en) Umlr polypeptides
AU1316201A (en) Polypeptide composition

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 15, NO 15, PAGE(S) 3116-3120 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 13162/01

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase